SAS | The Power to Know
cq5dam.thumbnail.319.319
White Paper

Enhancing Success Rates with Adaptive Clinical Trials

About this paper

Sponsors and clinical research organizations (CROs) are being very cautious in their utilization of adaptive clinical trial designs. And well they should be. While under the right circumstances, clinical trials can enhance the ethical treatment of patients, enable better decisions faster and help minimize the cost of clinical development, it is important to keep in mind that adaptive trials will not always be appropriate. This paper from Elsevier Business Intelligence discusses how adaptive clinical trials can provide a better way to explore and demonstrate the efficacy and safety of investigational products, while also emphasizing the point that a trial that forgoes validity for novelty is not a good trial.

About SAS

SAS is the leader in analytics. Through innovative analytics, business intelligence and data management software and services, SAS helps customers at more than 80,000 sites make better decisions faster. Since 1976, SAS has been giving customers around the world THE POWER TO KNOW®.

 

Vous avez un profil SAS? Pour compléter ce formulaire automatiquement Se connecter

*
*
*
*
 
*
*
 
  Oui, je souhaite recevoir occasionnellement des informations par email de la part de SAS Canada sur les produits, évènements, livres blancs, offres spéciales… Toutes vos données personnelles seront traitées conformément à notre politique de confidentialité.
 
 

Back to Top